Segall Bryant & Hamill LLC acquired a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 13,025 shares of the financial services provider's stock, valued at approximately $1,074,000.
Several other institutional investors have also modified their holdings of MET. Natixis purchased a new stake in MetLife in the 1st quarter worth about $224,000. CreativeOne Wealth LLC lifted its stake in shares of MetLife by 74.2% during the 1st quarter. CreativeOne Wealth LLC now owns 5,804 shares of the financial services provider's stock worth $430,000 after acquiring an additional 2,472 shares during the last quarter. EP Wealth Advisors LLC boosted its holdings in MetLife by 15.4% during the 1st quarter. EP Wealth Advisors LLC now owns 5,590 shares of the financial services provider's stock valued at $414,000 after acquiring an additional 747 shares during the period. SVB Wealth LLC grew its position in MetLife by 2.5% in the 1st quarter. SVB Wealth LLC now owns 10,115 shares of the financial services provider's stock valued at $750,000 after acquiring an additional 250 shares during the last quarter. Finally, Paloma Partners Management Co increased its stake in MetLife by 223.5% in the first quarter. Paloma Partners Management Co now owns 13,598 shares of the financial services provider's stock worth $1,008,000 after purchasing an additional 24,605 shares during the period. 89.81% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several research analysts recently commented on MET shares. TD Cowen started coverage on shares of MetLife in a research note on Wednesday, October 9th. They issued a "buy" rating and a $97.00 price target on the stock. Piper Sandler lifted their price target on shares of MetLife from $85.00 to $92.00 and gave the company an "overweight" rating in a research note on Wednesday, October 2nd. Bank of America dropped their price objective on MetLife from $99.00 to $96.00 and set a "buy" rating on the stock in a research note on Thursday, August 1st. StockNews.com upgraded MetLife from a "hold" rating to a "buy" rating in a report on Tuesday, November 12th. Finally, Barclays cut their price target on MetLife from $91.00 to $90.00 and set an "overweight" rating on the stock in a research note on Thursday, October 31st. Fourteen investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has an average rating of "Buy" and an average target price of $88.46.
Check Out Our Latest Report on MetLife
MetLife Stock Up 1.6 %
NYSE MET traded up $1.40 on Friday, hitting $86.59. The stock had a trading volume of 3,270,131 shares, compared to its average volume of 3,558,954. MetLife, Inc. has a 52-week low of $62.81 and a 52-week high of $86.94. The business's fifty day moving average price is $82.48 and its 200 day moving average price is $76.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market cap of $59.96 billion, a price-to-earnings ratio of 17.46, a price-to-earnings-growth ratio of 0.77 and a beta of 1.05.
MetLife Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be paid a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.52%. MetLife's payout ratio is 43.95%.
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.